Repro Med Systems, Inc (KRMD)

Etorro trading 970x250
Repro Med Systems, Inc (KRMD) Logo

About Repro Med Systems, Inc

Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York. Address: 24 Carpenter Road, Chester, NY, United States, 10918

Repro Med Systems, Inc News and around…

Latest news about Repro Med Systems, Inc (KRMD) common stock and company :

KORU Medical Systems to Unveil Updated Strategic Plan at Investor Day
01 Dec, 2021 FinancialContent

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced it will host an investor day to provide an update to its strategic plan.

What You Need To Know About Repro Med Systems, Inc.'s (NASDAQ:KRMD) Investor Composition
27 Nov, 2021 Yahoo! Finance

A look at the shareholders of Repro Med Systems, Inc. ( NASDAQ:KRMD ) can tell us which group is most powerful...

12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Nov, 2021 FinancialContent

Gainers Sundial Growers (NASDAQ:SNDL) stock increased by 28.49% to $0.93 during Friday's pre-market session. The ...

91 Biggest Movers From Yesterday
12 Nov, 2021 FinancialContent

Gainers NuZee, Inc. (NASDAQ: NUZE) shares jumped 164.5% to settle at $5.29 on Thursday. NuZee manufacturing partner, Cuvee Coffee, ...

12 Health Care Stocks Moving In Thursday's Intraday Session
11 Nov, 2021 FinancialContent

Gainers Liquidia (NASDAQ:LQDA) stock increased by 17.49% to $4.97 during Thursday's regular session. Trading volume for Liquidia's ...

54 Stocks Moving In Thursday's Mid-Day Session
11 Nov, 2021 FinancialContent

Gainers Pioneer Power Solutions, Inc. (NASDAQ: PPSI) shares gained 42.6% to $9.68. Pioneer Power Solutions recently announced the ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session
11 Nov, 2021 FinancialContent

Gainers ADMA Biologics (NASDAQ:ADMA) shares moved upwards by 11.42% to $1.56 during Thursday's pre-market session. ...

The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
11 Nov, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus MerckCommences ...

KORU Medical Shares Surge On FDA Approval For FreedomEdge Infusion Pump
11 Nov, 2021 FinancialContent

TheFDA gave 510k clearancetoRepro Med Systems IncdbaKORUMedical Systems(NASDAQ: KRMD) ...

KORU Medical Systems Announces 2021 Third Quarter Financial Results
10 Nov, 2021 FinancialContent

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today reported financial results for the third quarter ended September 30, 2021.

KORU Medical Announces FDA Clearance for Delivery of Hizentra® Prefilled Syringes
10 Nov, 2021 FinancialContent

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today announced 510k clearance for use of the KORU Medical FreedomEdge® infusion pump to deliver Hizentra® [immune globulin subcutaneous (human) 20% liquid] 20 mL prefilled syringes. Hizentra® is the most prescribed subcutaneous Ig product and the first to be available in a prefilled syringe format.

KORU Medical Systems to Participate in Two Upcoming Conferences
09 Nov, 2021 FinancialContent

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced its participation in two upcoming conferences, Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum and the 33rd Annual Piper Sandler Healthcare Conference.

KORU Medical Announces Collaboration With Gilero to Accelerate Innovation
08 Nov, 2021 FinancialContent

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing and commercialization of innovative and easy-to-use home infusion solutions, today announced its collaboration with Gilero, a medical device design and manufacturing company. Gilero offers unparalleled engineering and manufacturing solutions and has been a trusted partner for medical and drug delivery device companies for 20 years. The collaboration is part of KORU Medical’s strategic focus on innovation as the Company expands and evolves its at-home infusion products and portfolio.

KORU Medical Expands Senior Team to Accelerate Growth Strategy
01 Nov, 2021 FinancialContent

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced the appointment of two new leaders who will be responsible for key elements of the Company's growth strategy: Rob Cannon as the Company's new Vice President of Sales, and Brian Hertzog as the Company's new Vice President of BioPharma Business Development. Mr. Cannon will be responsible for U.S. sales and increasing the overall penetration of subcutaneous therapy for commercialized biopharmaceutical drugs. Mr. Hertzog will be responsible for leading biopharmaceutical business development and increasing the number of new biopharmaceutical drugs on the Freedom platform.

KORU Medical Systems to Report Third Quarter 2021 Financial Results on November 10, 2021
27 Oct, 2021 FinancialContent

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today announced that the Company will report third quarter 2021 financial results on Wednesday, November 10, 2021. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Earnings Preview: Repro Med Systems, Inc. (KRMD) Q3 Earnings Expected to Decline
26 Oct, 2021 Yahoo! Finance

Repro Med Systems, Inc. (KRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

KORU Medical Appoints Chris Pazdan as Vice President of Quality Assurance and Regulatory Affairs
26 Oct, 2021 FinancialContent

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced the appointment of Chris Pazdan as the Company's new Vice President of Quality Assurance and Regulatory Affairs. Mr. Pazdan will be responsible for all quality assurance and regulatory affairs as the Company continues to build out a robust Quality Management System and a regulatory strategy to meet evolving global standards.

48 Biggest Movers From Yesterday
21 Oct, 2021 FinancialContent

Gainers Xiaobai Maimai Inc. (NASDAQ: HX) shares surged 98.4% to settle at $18.87 on Wednesday on above-average volume. The company ...

32 Stocks Moving In Wednesday's Mid-Day Session
20 Oct, 2021 FinancialContent

Gainers Sesen Bio, Inc. (NASDAQ: SESN) rose 34.7% to $1.36. The FDA granted Sesen Bio’s request for a Type A meeting to ...

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
08 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Multiple insiders bought Repro Med Systems, Inc. (NASDAQ:KRMD) stock earlier this year, a positive sign for shareholders
28 Sep, 2021 Yahoo! Finance

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...

Analysts Have Been Trimming Their Repro Med Systems, Inc. (NASDAQ:KRMD) Price Target After Its Latest Report
14 Aug, 2021 Yahoo! Finance

Shareholders might have noticed that Repro Med Systems, Inc. ( NASDAQ:KRMD ) filed its quarterly result this time last...

Repro-Med Systems: Q2 Earnings Insights
11 Aug, 2021 FinancialContent

Shares of Repro-Med Systems (NASDAQ:KRMD) decreased 2.2% in after-market trading after the company reported Q2 results. Quarterly ...

KORU Medical Systems Announces 2021 Second Quarter Financial Results
11 Aug, 2021 FinancialContent

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today reported financial results for the second quarter ended June 30, 2021.

KORU Medical Systems Announces 2021 Second Quarter Financial Results
11 Aug, 2021 Yahoo! Finance

CHESTER, N.Y., August 11, 2021--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today reported financial results for the second quarter ended June 30, 2021.

The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
11 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

KORU Medical Systems to Participate in Canaccord Genuity’s 41st Annual Growth Conference
09 Aug, 2021 FinancialContent

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today announced that the Company will participate in Canaccord Genuity’s 41st Annual Growth Conference.

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
08 Aug, 2021 FinancialContent

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader ...

KORU Medical Systems to Report Second Quarter 2021 Financial Results on August 11, 2021
28 Jul, 2021 FinancialContent

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today announced that the Company will report second quarter 2021 financial results on Wednesday, August 11, 2021. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Earnings Preview: Repro Med Systems, Inc. (KRMD) Q2 Earnings Expected to Decline
27 Jul, 2021 Yahoo! Finance

Repro Med Systems, Inc. (KRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Repro Med Systems, Inc (KRMD) is a NASDAQ Common Stock listed in , ,

970x250